The Journal of Antimicrobial Chemotherapy is among the foremost international journals in antimicrobial research. Published monthly, the Journal features original articles on the laboratory ...

In the second of our Global Challenges, Chemistry Solutions features, we find out why we are developing an antimicrobial resistance programme and how we are supporting our community to address this ...

The threat of antimicrobial resistance (AMR) is augmented in the immunocompromised host because of overutilization of broad-spectrum antimicrobial therapy and inappropriate use of diagnostic testing.

In exploratory analyses, the 5-year overall survival in the nivolumab-plus-chemotherapy group was 95.3% (95% CI, 82.7 to 98.8) among the patients with a pathological complete response and 55.7% ...

Ivonescimab in Combination with Chemotherapy Reduces the Risk of Disease Progression or Death by 48% Compared to Chemotherapy Alone; Positive Overall Survival Trend Observed with Hazard Ratio of 0.79.

Ronan McCarthy receives funding from the BBSRC, NC3Rs, Academy of Medical Sciences, Horizon 2020, British Society for Antimicrobial Chemotherapy, Innovate UK, NERC and the Medical Research Council ...

Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer—the leading cause of cancer deaths worldwide—improved long-term survival overall compared with ...